Latest

“We have heard how difficult it has been to find standards and want to make it as easy as possible for the industry and suppliers to find the standards that can make product development and manufacturing processes more efficient.” Robert Shaw of SCB

“The COVID-19 pandemic could be an opportunity for the companies pursuing the development of gene therapies, as few products are in development to fight the viral illness.”
Alessio Brunello of GlobalData

Pyxis Oncology closes $152-million Series B financing to further advance portfolio